Landos Biopharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$21,935,000 over the previous period. Total operating expenses were $22,727,000.
Profit Margin
| 2018 | 0 | -6.04M | |
|---|---|---|---|
| 2019 | 0 | -13.93M | |
| 2020 | 0 | -30.14M | |
| 2021 | 18M | -38.22M | -212.37% |
| 2022 | 0 | -37.99M | |
| 2023 | 0 | -21.93M |
LABP Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 18M | 0 | 0 | 0 |
Cost of revenue | 0 | 577K | 196K | 137K | 103K | 0 |
Gross profit | 0 | -577K | 17.80M | -137K | -103K | 0 |
Operating exp. | ||||||
Research and development | 11.99M | 25.68M | 41.56M | 25.33M | 11.81M | 6.80M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 22.72M | 40.56M | 56.81M | 30.67M | 13.29M | 7.93M |
Operating income | -22.72M | -40.56M | -38.81M | -30.67M | -13.29M | -7.93M |
Other income (expenses), net | 792K | 1.28M | 394K | 532K | -177K | 1.89M |
Income before tax | -21.93M | -39.27M | -38.42M | -30.14M | -13.46M | -6.04M |
Income tax expense | 0 | -1.28M | -196K | 0 | 464K | 1.89M |
Net income | -21.93M | -37.99M | -38.22M | -30.14M | -13.93M | -6.04M |
Earnings per share | ||||||
Basic EPS | -3.5 | -9.44 | -9.5 | -7.51 | -3.47 | -2.62 |
Diluted EPS | -3.5 | -9.44 | -9.5 | -7.51 | -3.47 | -2.62 |
| Data source | Data source | Data source | Data source |